Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies

BACKGROUND: The multi-biomarker disease activity (MBDA) test measures 12 serum protein biomarkers to quantify disease activity in RA patients. A newer version of the MBDA score, adjusted for age, sex, and adiposity, has been validated in two cohorts (OPERA and BRASS) for predicting risk for radiogra...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Arthritis Res Ther
Glavni autori: Curtis, Jeffrey R., Weinblatt, Michael E., Shadick, Nancy A., Brahe, Cecilie H., Østergaard, Mikkel, Hetland, Merete Lund, Saevarsdottir, Saedis, Horton, Megan, Mabey, Brent, Flake, Darl D., Ben-Shachar, Rotem, Sasso, Eric H., Huizinga, T. W.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7784276/
https://ncbi.nlm.nih.gov/pubmed/33397438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02389-4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items